Phenylephrine Lawsuit Investigation: Decongestants Are Ineffective, FDA Panel Says

Last Updated on May 6, 2024

Investigation Complete

Comments |

At A Glance

This Alert Affects:
New York residents who purchased certain over-the-counter (OTC) cold, flu and allergy medications containing a decongestant known as phenylephrine.
What’s Going On?
In September 2023, a panel of FDA advisors declared that phenylephrine, a popular nasal decongestant found in many OTC cold and allergy medications, doesn’t work. Attorneys are now investigating whether consumers who purchased these products could take action via a class action lawsuit.
How Could a Class Action Lawsuit Help?
If filed and successful, a class action lawsuit could give consumers the chance to get back some of the money they spent on the medicine.